Literature DB >> 21539635

Randomized comparison between pulmonary vein antral isolation versus complex fractionated electrogram ablation for paroxysmal atrial fibrillation.

Minglong Chen1, Bing Yang, Hongwu Chen, Weizhu Ju, Fengxiang Zhang, Hung-Fat Tse, Kejiang Cao.   

Abstract

INTRODUCTION: Circumferential pulmonary vein antral isolation (PVAI) and atrial complex fractionated electrograms (CFEs) are both ablative techniques for the treatment of paroxysmal atrial fibrillation (PAF). However, data on the comparative value of these 2 ablation strategies are very limited. METHODS AND
RESULTS: We randomized 118 patients with drug-refractory PAF to receive PVAI ablation (n = 60) or CFE ablation (n = 58). For CFE group, spontaneous/induced AF was mapped using validated, automated software to guide ablation until all CFE areas were eliminated. For PVAI group, all 4 pulmonary vein antra were electrically isolated as confirmed by circular mapping catheter. Patients with spontaneous/inducible AF after the initial ablation procedure were crossed over to the other arms. After initial ablation procedure, AF persisted/inducible in 24/59 patients (41%), and 34/58 patients (59%) assigned to PVAI and CFE ablation, respectively (P = 0.05). Then 58 patients underwent PVAI + CFE ablation. After 22.6 ± 6.4 months, PVAI ablation group was more likely than CFE ablation group to achieve control of any AF/atrial tachycardia (AT) off drugs (43/60, 72% vs 33/58, 57%, P = 0.075) and lower recurrence rate of AT (11.9% vs 34.5%, P = 0.004). Patients who received CFE ablation alone (38%) had significantly lower overall success rate to achieve control of AF/AT off drugs compared with patients who received PVAI ablation (77%, P = 0.002) alone or PVAI + CFE ablation (69%, P = 0.008) due to higher recurrence rate of AT (50% vs 6% vs 13%, P < 0.01).
CONCLUSIONS: CFE ablation in PAF patients was associated with higher occurrence rate of postprocedure AT compared with PVAI ablation, whereby making it less likely to be a sole ablation strategy for PAF patients.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21539635     DOI: 10.1111/j.1540-8167.2011.02051.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

1.  Comparing efficacy and safety in catheter ablation strategies for atrial fibrillation: a network meta-analysis.

Authors:  Emmanouil Charitakis; Silvia Metelli; Lars O Karlsson; Antonios P Antoniadis; Konstantinos D Rizas; Ioan Liuba; Henrik Almroth; Anders Hassel Jönsson; Jonas Schwieler; Dimitrios Tsartsalis; Skevos Sideris; Elena Dragioti; Nikolaos Fragakis; Anna Chaimani
Journal:  BMC Med       Date:  2022-05-31       Impact factor: 11.150

2.  Atrial Substrate Modification in Atrial Fibrillation: Targeting GP or CFAE? Evidence from Meta-Analysis of Clinical Trials.

Authors:  Mu Qin; Xu Liu; Shao-Hui Wu; Xiao-Dong Zhang
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

3.  Does Additional Electrogram-Guided Ablation After Linear Ablation Reduce Recurrence After Catheter Ablation for Longstanding Persistent Atrial Fibrillation? A Prospective Randomized Study.

Authors:  Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  J Am Heart Assoc       Date:  2017-02-07       Impact factor: 5.501

4.  Meta-Analysis of Randomized Controlled Trials of Atrial Fibrillation Ablation With Pulmonary Vein Isolation Versus Without.

Authors:  Arunashis Sau; James P Howard; Sayed Al-Aidarous; João Ferreira-Martins; Becker Al-Khayatt; P Boon Lim; Prapa Kanagaratnam; Zachary I Whinnett; Nicholas S Peters; Markus B Sikkel; Darrel P Francis; S M Afzal Sohaib
Journal:  JACC Clin Electrophysiol       Date:  2019-07-31

Review 5.  Comparing Efficacy and Safety in Catheter Ablation Strategies for Paroxysmal Atrial Fibrillation: A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Emmanouil Charitakis; Silvia Metelli; Lars O Karlsson; Antonios P Antoniadis; Ioan Liuba; Henrik Almroth; Anders Hassel Jönsson; Jonas Schwieler; Skevos Sideris; Dimitrios Tsartsalis; Elena Dragioti; Nikolaos Fragakis; Anna Chaimani
Journal:  Diagnostics (Basel)       Date:  2022-02-09

6.  Meta-analysis of the therapeutic effects of various methods for the treatment of chronic atrial fibrillation.

Authors:  Gang Lin; Hui-He Lu; Yi Shen; Jian-Fei Huang; Lin-Sheng Shi; Yi-Nan Guo
Journal:  Exp Ther Med       Date:  2013-06-14       Impact factor: 2.447

Review 7.  Analytical approaches for myocardial fibrillation signals.

Authors:  Balvinder S Handa; Caroline H Roney; Charles Houston; Norman A Qureshi; Xinyang Li; David S Pitcher; Rasheda A Chowdhury; Phang Boon Lim; Emmanuel Dupont; Steven A Niederer; Chris D Cantwell; Nicholas S Peters; Fu Siong Ng
Journal:  Comput Biol Med       Date:  2018-07-17       Impact factor: 4.589

Review 8.  Atrial Fibrillation Mechanisms and Implications for Catheter Ablation.

Authors:  Ghassen Cheniti; Konstantinos Vlachos; Thomas Pambrun; Darren Hooks; Antonio Frontera; Masateru Takigawa; Felix Bourier; Takeshi Kitamura; Anna Lam; Claire Martin; Carole Dumas-Pommier; Stephane Puyo; Xavier Pillois; Josselin Duchateau; Nicolas Klotz; Arnaud Denis; Nicolas Derval; Pierre Jais; Hubert Cochet; Meleze Hocini; Michel Haissaguerre; Frederic Sacher
Journal:  Front Physiol       Date:  2018-10-17       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.